喘的性别差异:病理生理学,荷尔蒙影响和遗传机制
Richard Borrelli1, Luisa Brussino1,2, Luca Lo Sardo2
1Department of Medical Sciences, University of Turin, 10128 Turin, Italy.
International journal of molecular sciences
|June 13, 2025
概括
由于荷尔蒙,遗传和环境,喘的患病率和严重程度因性别而异. 了解这些基于性别的差异是开发个性化喘治疗的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 遗传学 是一个遗传学.
背景情况:
- 喘在患病率,严重程度和治疗反应方面存在显著的基于性别的差异.
- 青春期前的男孩患病率更高,而成年女性患病率和医疗保健利用率更高.
- 这些差异表明性激素,遗传因素和表观遗传调节的作用.
研究的目的:
- 探索性激素,遗传倾向和表观遗传因素对喘发病的影响.
- 了解这些因素是如何导致性别特异性喘表型和治疗反应的.
- 突出需要性特定的喘管理策略.
主要方法:
- 对喘患病率和性别差异的流行病学研究的审查.
- 分析性激素 (雌激素,孕,) 在免疫调节和炎症中的作用.
- 检查遗传 (X染色体基因,IL13,ORMDL3) 和表观遗传 (DNA甲基化,微RNA) 的影响.
- 考虑与生物性别相互作用的环境因素 (污染,肥胖,饮食).
主要成果:
- 性激素显著调节免疫反应,雌激素增强2型炎症,显示保护作用.
- 遗传因素,包括X链基因和性别依赖的基因表达,有助于性别特异的炎症特征.
- 表观遗传修饰和环境因素与生物性别相互作用,影响喘严重程度和治疗反应,特别是肥胖女性的类固醇耐药性.
- 成年女性患病率较高,结果较差,部分原因是荷尔蒙和遗传影响.
结论:
- 基于性别的喘差异是由激素,遗传学,表观遗传学和环境之间的复杂相互作用驱动的.
- 针对这些性别特定途径的个性化治疗策略对于优化喘管理至关重要.
- 未来的研究应该专注于基于性别的治疗干预措施,以改善疾病控制和减少医疗保健差异.
关键词:
在 FEV1 中,FEV1 是 FEV1.这就是FeNO FeNO.它们有IL-13和IL-13.IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL is is is is is is is what you are is what you are在TLR7中,在TLR8中,喘 喘 是一种雌激素是一种雌激素.一个女人,一个女人,一个女人.激素 激素 激素 激素 激素一个男的男的男的男的男的男这是一个小RNARNA.肥胖症 肥胖症 肥胖症 肥胖症孕激素是孕激素的一种.严重的喘 严重的喘在性爱中,性爱是性爱.女人 女人 女人 女人 女人
相关概念视频
01:20Asthma: Pathogenesis and Management
376
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
376
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
255
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
255